维普期刊资源整合服务平台（V6.5）

79篇 您的检索式：作者名="MOTRO M"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Geometrical nonlinear analysis of tensegrity systems显示文摘	Kebiche K Kazi-Aoual M N Motro R	1999	Engineering Structures1999，21，：	1
2	Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics显示文摘	MOTRO M SHEMESH J	2001	Hypertension2001，37，6：	1
3	Peroxisome proliferator-activated receptor 1igand bezafibrate for the prevention of type 2 diabetes mellitus in patients with coronary artery disease显示文摘	Motro M Fisman EZ	2004	Circulation2004，109，18：	1
4	Antihyperglycemic treatment in type 2 diabetics with coronary artery disease : facts and questions 显示文摘	Fisman EZ Tenenbaum A Motro M	2001	Heart Metab2001，11，：	1
5	Qral antidiabetic therapy in patients with heart disease 显示文摘	Fisman EZ Tenenbaum A Motro M	2004	Herz2004，3，：	1
6	Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: a marker for a worse prognosis显示文摘	Isman E Z Motro M Tenenbaum A	2001	Am Heart J2001，141，5：	1
7	Coronary benefits of calcium antagonist therapy for patients with hypertension显示文摘	Shemesh J Grossman E	2001	Current Opinion in Cardiology2001，16，：	1
8	Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome显示文摘	Tenenbaum A Motro M Fisman E Z		0，，：	1
9	Effect of bezafibrate on incidence of type 2 dibetes mellitus in obese patients 显示文摘	Tenenbaum A Motro M Fisman EZ	2005	Eur Heart J2005，26，19：	1
10	Calcium channal blocker nifiedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics显示文摘	Motro M Shemesh J	2001	Hypertension2001，37，6：	1
11	The combined cough frequency/severity scoring:a new approach to cough evaluation in clinical settings显示文摘	SHAPIRA I MOTRO M	2001	Journal of Medicine2001，32，34：	1
12	Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease:a marker for a worse prognosis显示文摘	Fisman E Z Motro M Tenenbaum A	2001	Am Heart J2001，141，：	1
13	Macrovascular complications of metabolic syndrome:an early intervention is imperative显示文摘	TENENBAUM A MOTRO M SCHWAMMENTHAI E	2004	Int J Cardiol2004，97，：	1
14	Oral antidiabetic therapy in patients with heart disease:a cardiologic standpoint显示文摘	Fisman EZ Tenenbaum A Motro M		0，，03：	1
15	Is hypoglycaemia a marker for increased long-term mortality risk in patients with coronary artery disease? An 8-year follow-up 显示文摘	Fisman EZ Motro M Tenenbaum A	2004	Eur J Cardiovasc Prey Rehabil2004，11，2：	1
16	Metabolic syndrome and type 2 diabetes mellitus:focus on peroxisome prolixferator activeated recaptors(PPAR) 显示文摘	Tenenbaum A Fisman E Z Motro M	2003	Cardiovascular Diabetology2003，2，1：	1
17	The combined cough frequency/severity scoring:a new approach to cough evaluation in clinical settings显示文摘	Fisman E Z Shapira I Motro M	2001	J Med2001，32，3：	1
18	Peroxisome pro-liferator-activated receptor ligand bezafibrate for prevention of type2diabetes mellitus in patients with coronary artery disease显示文摘	Tenenbaum A Motro M Fisman EZ	2004	Cir-culation2004，109，18：	1
19	Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR) 显示文摘	Tenenbaum A Fisman E Z Motro M	2003	Cardiovasc Diabetol2003，2，1：	1
20	Geometrical non-linear analysis of Tensegrity systems 显示文摘	KEBICHE K KAZI-AOUAL M MOTRO R	1999	Engineering Structures1999，21，5：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示